222 related articles for article (PubMed ID: 38011551)
1. HCMV-secreted glycoprotein gpUL4 inhibits TRAIL-mediated apoptosis and NK cell activation.
Vlachava VM; Seirafian S; Fielding CA; Kollnberger S; Aicheler RJ; Hughes J; Baker A; Weekes MP; Forbes S; Wilkinson GWG; Wang ECY; Stanton RJ
Proc Natl Acad Sci U S A; 2023 Dec; 120(49):e2309077120. PubMed ID: 38011551
[TBL] [Abstract][Full Text] [Related]
2. The Human Cytomegalovirus Protein UL148A Downregulates the NK Cell-Activating Ligand MICA To Avoid NK Cell Attack.
Dassa L; Seidel E; Oiknine-Djian E; Yamin R; Wolf DG; Le-Trilling VTK; Mandelboim O
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950412
[TBL] [Abstract][Full Text] [Related]
3. HCMV-Encoded NK Modulators: Lessons From
Patel M; Vlahava VM; Forbes SK; Fielding CA; Stanton RJ; Wang ECY
Front Immunol; 2018; 9():2214. PubMed ID: 30327650
[TBL] [Abstract][Full Text] [Related]
4. Genetic Variability of Human Cytomegalovirus Clinical Isolates Correlates With Altered Expression of Natural Killer Cell-Activating Ligands and IFN-γ.
Galitska G; Coscia A; Forni D; Steinbrueck L; De Meo S; Biolatti M; De Andrea M; Cagliani R; Leone A; Bertino E; Schulz T; Santoni A; Landolfo S; Sironi M; Cerboni C; Dell'Oste V
Front Immunol; 2021; 12():532484. PubMed ID: 33897679
[TBL] [Abstract][Full Text] [Related]
5. NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies.
Magri G; Muntasell A; Romo N; Sáez-Borderías A; Pende D; Geraghty DE; Hengel H; Angulo A; Moretta A; López-Botet M
Blood; 2011 Jan; 117(3):848-56. PubMed ID: 21030563
[TBL] [Abstract][Full Text] [Related]
6. Structure of human cytomegalovirus UL141 binding to TRAIL-R2 reveals novel, non-canonical death receptor interactions.
Nemčovičová I; Benedict CA; Zajonc DM
PLoS Pathog; 2013 Mar; 9(3):e1003224. PubMed ID: 23555243
[TBL] [Abstract][Full Text] [Related]
7. Leukocyte Immunoglobulin-Like Receptor 1-Expressing Human Natural Killer Cell Subsets Differentially Recognize Isolates of Human Cytomegalovirus through the Viral Major Histocompatibility Complex Class I Homolog UL18.
Chen KC; Stanton RJ; Banat JJ; Wills MR
J Virol; 2016 Jan; 90(6):3123-37. PubMed ID: 26739048
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cells can inhibit the transmission of human cytomegalovirus in cell culture by using mechanisms from innate and adaptive immune responses.
Wu Z; Sinzger C; Reichel JJ; Just M; Mertens T
J Virol; 2015 Mar; 89(5):2906-17. PubMed ID: 25540381
[TBL] [Abstract][Full Text] [Related]
9. Expression of the UL16 glycoprotein of Human Cytomegalovirus protects the virus-infected cell from attack by natural killer cells.
Valés-Gómez M; Browne H; Reyburn HT
BMC Immunol; 2003 Mar; 4():4. PubMed ID: 12694635
[TBL] [Abstract][Full Text] [Related]
10. Human Cytomegalovirus Immediate Early 86-kDa Protein Blocks Transcription and Induces Degradation of the Immature Interleukin-1β Protein during Virion-Mediated Activation of the AIM2 Inflammasome.
Botto S; Abraham J; Mizuno N; Pryke K; Gall B; Landais I; Streblow DN; Fruh KJ; DeFilippis VR
mBio; 2019 Feb; 10(1):. PubMed ID: 30755509
[TBL] [Abstract][Full Text] [Related]
11. The structure of cytomegalovirus immune modulator UL141 highlights structural Ig-fold versatility for receptor binding.
Nemčovičová I; Zajonc DM
Acta Crystallogr D Biol Crystallogr; 2014 Mar; 70(Pt 3):851-62. PubMed ID: 24598754
[TBL] [Abstract][Full Text] [Related]
12. Natural Killer Cells Adapt to Cytomegalovirus Along a Functionally Static Phenotypic Spectrum in Human Immunodeficiency Virus Infection.
Holder KA; Lajoie J; Grant MD
Front Immunol; 2018; 9():2494. PubMed ID: 30483249
[TBL] [Abstract][Full Text] [Related]
13. Identification and Functional Characterization of a Novel Fc Gamma-Binding Glycoprotein in Rhesus Cytomegalovirus.
Kolb P; Sijmons S; McArdle MR; Taher H; Womack J; Hughes C; Ventura A; Jarvis MA; Stahl-Hennig C; Hansen S; Picker LJ; Malouli D; Hengel H; Früh K
J Virol; 2019 Feb; 93(4):. PubMed ID: 30487278
[TBL] [Abstract][Full Text] [Related]
14. Hcmv-miR-UL112 attenuates NK cell activity by inhibition type I interferon secretion.
Huang Y; Chen D; He J; Cai J; Shen K; Liu X; Yang X; Xu L
Immunol Lett; 2015 Feb; 163(2):151-6. PubMed ID: 25530545
[TBL] [Abstract][Full Text] [Related]
15. Extent of Cytomegalovirus Replication in the Human Host Depends on Variations of the HLA-E/UL40 Axis.
Vietzen H; Rückert T; Hartenberger S; Honsig C; Jaksch P; Geleff S; Hammer Q; Romagnani C; Segura-Wang M; Puchhammer-Stöckl E
mBio; 2021 Mar; 12(2):. PubMed ID: 33727352
[TBL] [Abstract][Full Text] [Related]
16. Human cytomegalovirus glycoprotein UL141 targets the TRAIL death receptors to thwart host innate antiviral defenses.
Smith W; Tomasec P; Aicheler R; Loewendorf A; Nemčovičová I; Wang EC; Stanton RJ; Macauley M; Norris P; Willen L; Ruckova E; Nomoto A; Schneider P; Hahn G; Zajonc DM; Ware CF; Wilkinson GW; Benedict CA
Cell Host Microbe; 2013 Mar; 13(3):324-35. PubMed ID: 23498957
[TBL] [Abstract][Full Text] [Related]
17. Membrane-bound TRAIL supplements natural killer cell cytotoxicity against neuroblastoma cells.
Sheard MA; Asgharzadeh S; Liu Y; Lin TY; Wu HW; Ji L; Groshen S; Lee DA; Seeger RC
J Immunother; 2013 Jun; 36(5):319-29. PubMed ID: 23719242
[TBL] [Abstract][Full Text] [Related]
18. Engagement of TRAIL triggers degranulation and IFNγ production in human natural killer cells.
Höfle J; Trenkner T; Kleist N; Schwane V; Vollmers S; Barcelona B; Niehrs A; Fittje P; Huynh-Tran VH; Sauter J; Schmidt AH; Peine S; Hoelzemer A; Richert L; Altfeld M; Körner C
EMBO Rep; 2022 Aug; 23(8):e54133. PubMed ID: 35758160
[TBL] [Abstract][Full Text] [Related]
19. Monocytes inhibit hepatitis C virus-induced TRAIL expression on CD56
Mele D; Mantovani S; Oliviero B; Grossi G; Lombardi A; Mondelli MU; Varchetta S
J Hepatol; 2017 Dec; 67(6):1148-1156. PubMed ID: 28803951
[TBL] [Abstract][Full Text] [Related]
20. Human cytomegalovirus Fcγ binding proteins gp34 and gp68 antagonize Fcγ receptors I, II and III.
Corrales-Aguilar E; Trilling M; Hunold K; Fiedler M; Le VT; Reinhard H; Ehrhardt K; Mercé-Maldonado E; Aliyev E; Zimmermann A; Johnson DC; Hengel H
PLoS Pathog; 2014 May; 10(5):e1004131. PubMed ID: 24830376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
